Regeneron Pharmaceuticals Inc (REGN)
Return on assets (ROA)
| Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 4,578,000 | 4,458,600 | 4,499,300 | 4,412,600 | 4,654,500 | 4,321,700 | 3,857,800 | 3,953,600 | 3,991,100 | 4,299,000 | 4,182,700 | 4,338,400 | 5,370,300 | 5,686,800 | 7,933,600 | 8,075,300 | 6,995,500 | 6,205,400 | 4,003,800 | 3,513,200 |
| Total assets | US$ in thousands | 40,169,400 | 38,219,200 | 37,545,200 | 37,759,400 | 37,441,900 | 36,086,800 | 34,369,600 | 33,080,200 | 32,163,300 | 30,657,500 | 30,059,900 | 29,214,500 | 27,677,800 | 27,205,800 | 26,348,700 | 25,434,800 | 23,671,500 | 21,485,900 | 17,772,200 | 17,163,300 |
| ROA | 11.40% | 11.67% | 11.98% | 11.69% | 12.43% | 11.98% | 11.22% | 11.95% | 12.41% | 14.02% | 13.91% | 14.85% | 19.40% | 20.90% | 30.11% | 31.75% | 29.55% | 28.88% | 22.53% | 20.47% |
September 30, 2025 calculation
ROA = Net income (ttm) ÷ Total assets
= $4,578,000K ÷ $40,169,400K
= 11.40%
Peer comparison
Sep 30, 2025
Company name
Symbol
ROA
Regeneron Pharmaceuticals Inc
REGN
11.40%
Arrowhead Pharmaceuticals Inc
ARWR
-0.12%
Biomarin Pharmaceutical Inc
BMRN
6.83%
See also:
Regeneron Pharmaceuticals Inc Return on Assets (ROA) (Quarterly Data)